Report Summary
Summary
Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs.
Surgical therapy treatment segment is expected to account for major share in global liposarcoma treatment market as it is the choice of treatment recommended by majority of cancer specialists. Most of the physicians do not rely on chemotherapy for the liposarcoma treatment however, it can be used prior to the surgery to reduce the size of the tumor making it the second largest segment in terms of value in global liposarcoma treatment market. Radiation therapy treatment is used to avoid recurrence of the liposarcoma after surgery and contributes a minimal share in global liposarcoma treatment market.
North America is anticipated to lead the global liposarcoma treatment market due to relatively greater prevalence of the disease in the region. APAC and MEA regions are expected to witness steady market growth owing to lack of awareness about the disease.
In 2020, the global Liposarcoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Liposarcoma Treatment market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2021-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Johnson & Johnson
Pfizer
Eli Lilly
Sanofi SA
Novartis AG
Baxter International
Bristol Laboratories
Teva Pharmaceutical Industries
Mylan N.V
Actavis
Fresenius Kabi
Accord Healthcare
Taro Pharmaceuticals
Sandoz
Bedford Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Surgical Therapy
Market segment by Application, the market can be split into
Hospitals
Multispecialty Clinics
Cancer Treatment and Rehabilitation Centers
The study objectives of this report are:
To study and forecast the market size of Liposarcoma Treatment in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Liposarcoma Treatment are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Liposarcoma Treatment market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table of Contents
Liposarcoma Treatment Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Liposarcoma Treatment
1.1 Liposarcoma Treatment Market Overview
1.1.1 Liposarcoma Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Liposarcoma Treatment Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Liposarcoma Treatment Market by Type
1.3.1 Chemotherapy
1.3.2 Radiation Therapy
1.3.3 Surgical Therapy
1.4 Liposarcoma Treatment Market by End Users/Application
1.4.1 Hospitals
1.4.2 Multispecialty Clinics
1.4.3 Cancer Treatment and Rehabilitation Centers
2 Global Liposarcoma Treatment Competition Analysis by Players
2.1 Liposarcoma Treatment Market Size (Value) by Players (2019 and 2020)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Johnson & Johnson
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Pfizer
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 Eli Lilly
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.3.5 Recent Developments
3.4 Sanofi SA
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.4.5 Recent Developments
3.5 Novartis AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.5.5 Recent Developments
3.6 Baxter International
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.6.5 Recent Developments
3.7 Bristol Laboratories
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.7.5 Recent Developments
3.8 Teva Pharmaceutical Industries
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.8.5 Recent Developments
3.9 Mylan N.V
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.9.5 Recent Developments
3.10 Actavis
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Liposarcoma Treatment Revenue (Value) (2017-2020)
3.10.5 Recent Developments
3.11 Fresenius Kabi
3.12 Accord Healthcare
3.13 Taro Pharmaceuticals
3.14 Sandoz
3.15 Bedford Laboratories
4 Global Liposarcoma Treatment Market Size by Type and Application (2017-2020)
4.1 Global Liposarcoma Treatment Market Size by Type (2017-2020)
4.2 Global Liposarcoma Treatment Market Size by Application (2017-2020)
4.3 Potential Application of Liposarcoma Treatment in Future
4.4 Top Consumer/End Users of Liposarcoma Treatment
5 North America Liposarcoma Treatment Development Status and Outlook
5.1 North America Liposarcoma Treatment Market Size (2017-2020)
5.2 North America Liposarcoma Treatment Market Size and Market Share by Players (2019 and 2020)
6 Europe Liposarcoma Treatment Development Status and Outlook
6.1 Europe Liposarcoma Treatment Market Size (2017-2020)
6.2 Europe Liposarcoma Treatment Market Size and Market Share by Players (2019 and 2020)
7 China Liposarcoma Treatment Development Status and Outlook
7.1 China Liposarcoma Treatment Market Size (2017-2020)
7.2 China Liposarcoma Treatment Market Size and Market Share by Players (2019 and 2020)
8 Rest of Asia Pacific Liposarcoma Treatment Development Status and Outlook
8.1 Rest of Asia Pacific Liposarcoma Treatment Market Size (2017-2020)
8.2 Rest of Asia Pacific Liposarcoma Treatment Market Size and Market Share by Players (2019 and 2020)
9 Central & South America Liposarcoma Treatment Development Status and Outlook
9.1 Central & South America Liposarcoma Treatment Market Size (2017-2020)
9.2 Central & South America Liposarcoma Treatment Market Size and Market Share by Players (2019 and 2020)
10 Middle East & Africa Liposarcoma Treatment Development Status and Outlook
10.1 Middle East & Africa Liposarcoma Treatment Market Size (2017-2020)
10.2 Middle East & Africa Liposarcoma Treatment Market Size and Market Share by Players (2019 and 2020)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Liposarcoma Treatment Market Size (Value) by Regions (2021-2027)
11.1.1 North America Liposarcoma Treatment Revenue and Growth Rate (2021-2027)
11.1.2 Europe Liposarcoma Treatment Revenue and Growth Rate (2021-2027)
11.1.3 China Liposarcoma Treatment Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Liposarcoma Treatment Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Liposarcoma Treatment Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Liposarcoma Treatment Revenue and Growth Rate (2021-2027)
11.2 Global Liposarcoma Treatment Market Size (Value) by Type (2021-2027)
11.3 Global Liposarcoma Treatment Market Size by Application (2021-2027)
12 Liposarcoma Treatment Market Dynamics
12.1 Liposarcoma Treatment Market Opportunities
12.2 Liposarcoma Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Liposarcoma Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Liposarcoma Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
